SHW
The Sherwin-Williams Company
NYSE · Basic Materials · Chemicals - Specialty · US
$333.71
+0.44%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 24.4B | 23.6B | 23.1B | 23.1B | 22.1B |
| Cost of Revenue | 12.4B | 12.0B | 11.9B | 12.3B | 12.8B |
| Gross Profit | 12.0B | 11.5B | 11.2B | 10.8B | 9.3B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 8.0B | 7.7B | 7.4B | 7.1B | 6.3B |
| General & Admin Expense | 5.9B | 7.7B | 7.4B | 7.1B | 6.3B |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 21.2M | 21.3M | (1.3M) | 80.7M | (7.1M) |
| Total Operating Expenses | 8.0B | 7.7B | 7.4B | 7.2B | 6.3B |
| Cost and Expenses | 20.4B | 19.8B | 19.3B | 19.4B | 19.1B |
| Operating Income (EBIT) | 4.0B | 3.8B | 3.8B | 3.6B | 3.0B |
| Non-Operating | |||||
| Interest Income | 13.7M | 11.2M | 11.0M | 25.2M | 8.0M |
| Interest Expense | 516.3M | 468.9M | 431.4M | 432.5M | 403.0M |
| Net Interest Income | (502.6M) | (457.7M) | (420.4M) | (407.3M) | (395.0M) |
| Other Non-Op Income/Expense | (501.4M) | (466.6M) | (310.1M) | (496.5M) | (427.5M) |
| Non-Operating Income (excl Interest) | (14.9M) | (2.3M) | (105.6M) | 79.0M | 36.7M |
| EBT (Pre-Tax Income) | 3.5B | 3.3B | 3.5B | 3.1B | 2.6B |
| Income Tax Expense | 803.6M | 769.7M | 770.4M | 721.1M | 553.0M |
| Bottom Line | |||||
| Net Income | 2.7B | 2.6B | 2.7B | 2.4B | 2.0B |
| Earnings from Cont. Ops | 2.7B | 2.6B | 2.7B | 2.4B | 2.0B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 2.7B | 2.6B | 2.7B | 2.4B | 2.0B |
| Per Share | |||||
| Basic EPS | $10.95 | $10.38 | $10.68 | $9.35 | $7.83 |
| Diluted EPS | $10.85 | $10.27 | $10.55 | $9.25 | $7.72 |
| Revenue Per Share | $99.72 | $95.67 | $90.90 | $90.26 | $85.85 |
| Shares | |||||
| Basic Shares Outstanding | 244.8M | 246.4M | 254.1M | 255.4M | 258.0M |
| Diluted Shares Outstanding | 247.1M | 248.8M | 254.1M | 258.3M | 261.8M |
| Profitability Metrics | |||||
| EBITDA | 4.5B | 4.4B | 4.5B | 4.1B | 3.5B |
| D&A | 452.0M | 588.8M | 624.0M | 622.5M | 581.1M |
| EBIT | 4.0B | 3.8B | 3.9B | 3.5B | 3.0B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026